<?xml version="1.0" encoding="UTF-8"?>
<ref id="B278-vaccines-08-00036">
 <label>278.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Covassin</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Jangalwe</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jouvet</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Laning</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Burzenski</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Shultz</surname>
    <given-names>L.D.</given-names>
   </name>
   <name>
    <surname>Brehm</surname>
    <given-names>M.A.</given-names>
   </name>
  </person-group>
  <article-title>Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rgamma(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells</article-title>
  <source>Clin. Exp. Immunol.</source>
  <year>2013</year>
  <volume>174</volume>
  <fpage>372</fpage>
  <lpage>388</lpage>
  <pub-id pub-id-type="doi">10.1111/cei.12180</pub-id>
  <?supplied-pmid 23869841?>
  <pub-id pub-id-type="pmid">23869841</pub-id>
 </element-citation>
</ref>
